🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate the statistical non inferiority of the combination of latano...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-07
Trial ID
NCT00140049
This study compares the efficacy and tolerability/comfort of brimonidine/ti...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00822081
Treatments Being Tested
The purpose of this study is to evaluate AZORGA® Ophthalmic Suspension comp...
Status
Completed
Location
Contact Alcon Japan Ltd. for Trial Locations
Start Date
2014-12
Trial ID
NCT02325518
This study was designed to compare the 24-hour efficacy on intra ocular pre...
Status
Completed
Location
University Eye Clinic
Start Date
2002-01
Trial ID
NCT01655758
Treatments Being Tested
The study investigated the 24-hour efficacy and ocular surface health with ...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02802137
Treatments Being Tested
The goal of this study is to evaluate the tolerability of the new formulati...
Status
Completed
Location
Clínica de Ojos Dr. Nano
Start Date
2023-03-07
Trial ID
NCT05857267
Treatments Being Tested
To prove the non-inferiority of the fixed timolol-dorzolamide combination (...
Status
Completed
Location
Seoul St. Mary's hospital
Start Date
2011-03
Trial ID
NCT01175902
Treatments Being Tested
Glaucoma is one of the leading causes of blindness worldwide that is a chro...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT03966560
The proposed study will compare for the first time the quality of 24-hour I...
Status
Completed
Location
Glaucoma Unit, 1st University Dept of Ophthalmology
Start Date
2009-01
Trial ID
NCT00972257
Treatments Being Tested
Glaucoma is an optic neuropathy in which the main risk factor is intraocula...
Status
Completed
Location
University Hospitals Leuven
Start Date
2014-01
Trial ID
NCT02053298
Treatments Being Tested